title: Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.
abstract: Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent underlying Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. This human gammaherpesvirus was discovered in 1994 by Drs. Yuan Chang and Patrick Moore. Today, there are over five thousand publications on KSHV and its associated malignancies. In this article, we review recent and ongoing developments in the KSHV field, including molecular mechanisms of KSHV pathogenesis, clinical aspects of KSHV-associated diseases, and current treatments for cancers associated with this virus.
authors: Dirk P
authors: DP
authors: Dittmer
authors: Blossom
authors: B
authors: Damania
mesh_terms: D000818:Animals; D063646:Carcinogenesis; D002471:Cell Transformation, Neoplastic; D004268:DNA-Binding Proteins / Q000378:metabolism; D023281:Genomics; D019288:Herpesvirus 8, Human; D006801:Humans; D007113:Immunity, Innate; D007249:Inflammation; D035683:MicroRNAs / Q000378:metabolism; D012514:Sarcoma, Kaposi / Q000235:genetics / Q000276:immunology* / Q000628:therapy*; D015398:Signal Transduction; D051193:Toll-Like Receptors / Q000378:metabolism
chemical_list: D004268:DNA-Binding Proteins; D035683:MicroRNAs; D051193:Toll-Like Receptors